New Edge Advisors, LLC Vaxxinity, Inc. Call Options Transaction History
New Edge Advisors, LLC
- $13.5 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VAXX
# of Institutions
4Shares Held
265KCall Options Held
0Put Options Held
0About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...